US Patent Issued to Compass Therapeutics on Nov. 11 for "Transgenic mouse expressing common human light chain" (Massachusetts Inventor)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,467,062, issued on Nov. 11, was assigned to Compass Therapeutics LLC (Cambridge, Mass.).

"Transgenic mouse expressing common human light chain" was invented by Michael March Schmidt (Wellesley, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a transgenic non-human mammal (e.g., mouse) that expresses a common light chain, wherein the transgenic non-human mammal comprises a hybrid light chain locus from which a light chain having a human VKappa joined to a mouse JKappa is expressed. Also provided are methods of making a transgenic non-human mammal capable of expressing a common light chain."

The patent was filed on ...